Citius Pharmaceuticals Inc. Common Share Price
NASDAQ: CTXRHealthcare
Live Citius Pharmaceuticals Inc. Common Share Price Chart
O H L
Citius Pharmaceuticals Inc. Common Performance Overview
Days Range
▼
$0.59Low
$0.59High
Markets Today
| Previous Close | $0.59 |
|---|---|
| Open | $0.59 |
| Volume | 46,736 |
| Day's Range | $0.59 - $0.59 |
| 52W Range | $0.47 - $2.19 |
| Market Cap | $15.37 M |
Historical Performance
| 1M Returns | +2.82 |
|---|---|
| 3M Returns | +7.60 |
| 6M Returns | -28.79 |
| 1Y Returns | -49.75 |
| 5Y Returns | -98.87 |
| 10Y Returns | NA |
Citius Pharmaceuticals Inc. Common Fundamentals
| Market Cap | $15.37 M |
|---|---|
| Dividend yield | 0.00 |
| PE Ratio | 0.00 |
| PEG Ratio | N/A |
| Revenue | $0.00 |
| ROE TTM | -0.54 |
| EPS TTM | $-2.13 |
| Quarterly Earnings Growth YOY | N/A |
| PB Ratio | 0.23 |
| EBITDA | $-38.53 M |
| Profit Margin | N/A |
| Market Cap | $15.37 M |
|---|---|
| Dividend yield | 0.00 |
| PE Ratio | 0.00 |
| PEG Ratio | N/A |
| Revenue | $0.00 |
| ROE TTM | -0.54 |
| EPS TTM | $-2.13 |
|---|---|
| Quarterly Earnings Growth YOY | N/A |
| PB Ratio | 0.23 |
| EBITDA | $-38.53 M |
| Profit Margin | N/A |
Citius Pharmaceuticals Inc. Common Profit & Loss
Quarterly
| Mar 2025 | Jun 2025 | Sep 2025 | Dec 2025 | Mar 2026 | Jun 2026 | |
|---|---|---|---|---|---|---|
| Total Revenue + | $0 | $0 | $0 | $3.94 M | $1.67 M | $1.49 M |
| Gross Profit + | $0 | $0 | $0 | $3.15 M | $1.34 M | $1.00 M |
| Operating Income | -$11.26 M | -$8.79 M | -$8.44 M | -$9.02 M | -$32.19 M | -$11.73 M |
| EBITDA | -$11.26 M | -$8.79 M | -$8.44 M | -$9.02 M | -$32.19 M | -$11.73 M |
| Interest Expense | $0 | -$172.26 K | -$95.52 K | -$155.54 K | -$33.03 K | -$231.73 K |
| Depreciation | $0 | $0 | $0 | $0 | $0 | $0 |
| Income Before Tax | -$11.25 M | -$8.94 M | -$8.48 M | -$9.13 M | -$28.34 M | -$12.03 M |
| Income Tax Expense | $264.24 K | $264.24 K | $264.24 K | $264.24 K | -$231.21 K | -$107.35 K |
| Net Income + | -$11.51 M | -$9.20 M | -$8.74 M | -$9.39 M | -$28.11 M | -$11.92 M |
| Net Profit Margin | - | - | - | -238.18% | -1685.95% | -797.92% |
Citius Pharmaceuticals Inc. Common Financials Balance Sheet In USD
Quarterly
| Mar 2025 | Jun 2025 | Sep 2025 | Dec 2025 | Mar 2026 | Jun 2026 | |
|---|---|---|---|---|---|---|
| Share Capital | $8.76 K | $14.47 K | $18.07 K | $22.38 K | $22.38 K | $27.45 K |
| Reserve & Surplus | -$222.05 M | -$230.84 M | -$238.80 M | -$247.02 M | -$268.26 M | -$277.12 M |
| Non-Current Liabilities | $8.03 M | $8.27 M | $8.50 M | $8.72 M | $8.44 M | $14.70 M |
| Current Liabilities | $49.88 M | $51.84 M | $44.91 M | $38.21 M | $55.02 M | $51.65 M |
| Total Liabilities | $57.91 M | $60.12 M | $53.41 M | $46.92 M | $63.46 M | $66.35 M |
| Fixed Assets | $92.80 M | $92.80 M | $92.80 M | $92.23 M | $90.51 M | $88.79 M |
| Current Assets | $18.37 M | $24.61 M | $27.93 M | $37.95 M | $31.69 M | $43.33 M |
| Total Assets | $121.48 M | $127.68 M | $130.94 M | $140.39 M | $132.54 M | $142.26 M |
Citius Pharmaceuticals Inc. Common Cash Flow
Quarterly
| Mar 2025 | Jun 2025 | Sep 2025 | Dec 2025 | Mar 2026 | Jun 2026 | |
|---|---|---|---|---|---|---|
| Net Income | -$11.51 M | -$9.20 M | -$8.74 M | -$9.39 M | -$28.11 M | -$11.92 M |
| Operating Cash Flow | -$4.54 M | -$5.41 M | -$11.88 M | -$13.01 M | -$1.30 M | -$8.68 M |
| Investing Cash Flow | $0 | $0 | -$5.75 M | -$4.40 M | -$600.00 K | -$2.00 M |
| Financing Cash Flow | $3.47 M | $11.47 M | $15.79 M | $20.88 M | -$1.23 M | $23.09 M |
| Change in Cash | -$1.07 M | $6.06 M | -$1.84 M | $3.47 M | -$3.13 M | $12.42 M |
Citius Pharmaceuticals Inc. Common Return Calculator
The Citius Pharmaceuticals Inc. Common stock calculator helps Indian investors calculate returns based on the historical performance of the stock. Just choose your investment amount and duration to get insights and invest more confidently. See stock returns as well as the effect of dollar appreciation over different durations.
*Dollar Impact: The bonus return you make when the US Dollar rises against the Rupee; calculated on the full amount you walk away with, not just what you invested in.
Returns Estimator
Based on past performance of this fund
ENTER AMOUNT
$10,000
Select Duration
5Yrs
1 Yr5 Yrs
If you had invested $10,000 5 years ago, what would its value be today?$113
Invested Amount$10,000
Est. Returns$-9,887
About Citius Pharmaceuticals Inc. Common
Citius Pharmaceuticals Inc is a biopharmaceutical company dedicated to the development and commercialization of first-in-class critical care products, with a focus on oncology, anti-infectives in adjunct cancer care and distinct prescription products. It aims to provide therapeutic products that address unmet medical needs yet have a lower development risk than is usually associated with new chemical entities. The company's flagship product candidate is LYMPHIR, an engineered IL-2 diphtheria toxin fusion protein. It operates through a single operating and reportable segment which is focused on developing and commercializing pioneering targeted oncology therapies.
Popular Stocks
FAQs
What is the share price of Citius Pharmaceuticals Inc. Common today?
Citius Pharmaceuticals Inc. Common (CTXR) share price as of September 18, 2026 is $0.59. If you are investing from India, you can always check the valuation in the INR before investing.
Can Indian Investors purchase shares of Citius Pharmaceuticals Inc. Common?
Yes, Indian Investors can invest in the Citius Pharmaceuticals Inc. Common (CTXR) Share by opening an international trading account with Angel One.
How can I purchase Citius Pharmaceuticals Inc. Common shares in India?
Purchasing Citius Pharmaceuticals Inc. Common (CTXR) share from India can be done by: Directly: By opening an international trading account with Angel One. The process would include KYC verification. The account activation takes a few minutes to a few hours, after which you can start buying Citius Pharmaceuticals Inc. Common (CTXR) by making deposits in US dollars. Indirectly: By investing in mutual funds and Exchange Traded Funds (ETF) that offers exposure in global stocks.
Can I buy Fractional shares of Citius Pharmaceuticals Inc. Common?
Yes, you can purchase fractional shares of Citius Pharmaceuticals Inc. Common (CTXR) or any other US company shares in Angel One for any dollar amount.
What is the market capitalization value of Citius Pharmaceuticals Inc. Common?
The market capitalization of Citius Pharmaceuticals Inc. Common on September 18, 2026, is $15.37 M.
In which sector Citius Pharmaceuticals Inc. Common belongs?
Citius Pharmaceuticals Inc. Common operates in the Healthcare sector, specifically in the Healthcare industry.
What documents are required to invest in Citius Pharmaceuticals Inc. Common stocks?
In order to invest in Citius Pharmaceuticals Inc. Common (CTXR) you will need Proof of Identification (Aadhaar, PAN, Passport etc.) and Proof of Address (Aadhaar, Voter Card etc.). From start to end, the process is digital and can be seamless.
Diversify Your Portfolio with US Stocks
Invest in Wall Street Giants from India
